ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2023
Olfactory Hallucinations Following COVID-19 Vaccination.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaccine-induced phantosmia is a rare adverse effect of vaccination and has not been previously reported related to the Johnson & Johnson (J&J) COVID-19 vaccine. Case Presentation: Three weeks after receiving the J&J COVID-19 vaccine, a 39-year-old veteran started smelling a burning odor in the absence of an identifiable source. At presentation to the clinic, his general and neurological examinations, brain magnetic resonance imaging, and electroencephalogram were all unremarkable. The episodes persisted for nearly 2 years (21 months postvaccination). Conclusions: This is the only case of phantosmia reported after the use of the J&J COVID-19 vaccine and aligns with the literature that reports 1 case of phantosmia and 2 cases of hyposmia following the Pfizer-BioNTech COVID-19 mRNA vaccine. This information will help health care professionals understand the possible adverse effects of COVID-19 vaccination and be better equipped to counsel patients about the benign but potentially long-lasting adverse effects of the J&J COVID-19 vaccine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.